Lung Cancer Diagnostics Market Report: Trends, Insights, and Forecast for 2030

According to the study by Next Move Strategy Consulting, the global Lung Cancer Diagnostics Market is predicted to reach USD 5.91 billion with a CAGR of 10.4% by 2030. 

This market includes various diagnostic tools and techniques, such as imaging technologies (CT scans, PET scans, and MRI), molecular diagnostics, biomarker tests, and biopsy procedures. 

The rising incidence of cancer cases, particularly lung cancer due to factors such as smoking, environmental pollutants, and genetic factors, accelerates the need for advanced diagnostic technologies, thereby driving the growth of the market. 

Request for a FREE Sample PDF: https://www.nextmsc.com/lung-cancer-diagnostics-market/request-sample